ESCP is investigating the variety in wound closure techniques and surgical site infection preventive strategies. We hope to gather as many individual responses as possible and would be grateful if you could complete the survey.
The Time To Act campaign, which aims to tackle the stalling of cancer treatment during the pandemic, was launched in May. Professor Antonino Spinelli, ESCP General Secretary, took part in the campaign event and is interviewed here by Nagendra Dudi-Venkata and Yongbo An from ESCP's SoMe Subcommittee.
Cristián Gallardo interviews Soo Young Lee from Chonnam National University Hwasun Hospital in Korea in the run-up to ESCP's next Global Reach webinar 'Myths and Evidence in Diverticular Disease'.
June’s paper of the month looks at the PRODIGE-23 trial, a randomised phase 3 clinical trial which sought to determine whether total neoadjuvant chemotherapy (TNT) before surgery improved disease-free survival (DFS) compared with standard preoperative chemoradiotherapy (CRT) in patients with locally advanced rectal cancer.
Vittoria Bellato interviews Mr Shahnawaz Rasheed, Consultant Surgeon at The Royal Marsden, London, about his experience of robotic-assisted pelvic exenteration.